Sunil S. Badve, MD, FRCPath, is vice chair for Pathology Cancer Programs and a professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. A surgical pathologist and a translational researcher with expertise in breast cancer and thymic pathology, Dr. Badve has made seminal contributions to the role of tumor infiltrating lymphocytes in triple negative breast cancer and re-classification of thymic tumors. He is working through his research and collaborations to reimagine risk assessment in and capitalize on novel approaches to improve management of patients with breast cancer.
Prior to joining Emory, Dr. Badve was on faculty at Indiana University in Indianapolis, Indiana and at Northwestern University, Chicago, Illnois.
Dr. Badve is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute of Emory University in Atlanta, Georgia.. He is an active member of ECOG-ACRIN Cancer Research Group, where he serves as the central pathologist (pathology chair) for several breast cancer clinical trials. He also holds a professional membership with United States and Canadian Academy of Pathologists. He is a pathology member of the National Cancer Institute's Breast Cancer Steering Committee.
Dr. Badve's translational research efforts focus on novel prognostic/ predictive markers in breast and thymic tumors. His team developed and patented gene signatures for thymomas and ER+ breast cancer. His current work involves studying the individual biological components that culminate development of cancer in patients with DCIS. The lab specifically seeks to apply multi-omics tools to understand tumor heterogeneity and gaining a better understanding of molecular mechanisms related to tumor aggressiveness.
Dr. Badve serves as the pathology chair for several large clinical trials including TAILORx, COMPASSHER2, COMET and EA4112.
Dr. Badve has over 260 peer-reviewed scientific articles and has edited two books, Molecular Pathology of Breast Cancer and Predictive Biomarkers. He is associate editor of Clinical Breast Cancer and serves on the editorial board of several journals including JCO Precision Medicine and BMC Cancer.
In 2021, Dr. Badve was inducted to the MilliPub Club, which recognizes current Emory faculty who have published one or more individual papers throughout their careers that have garnered more than 1,000 citations.
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
Virchows Archiv : an international journal of pathology |
J Rüschoff, G Kumar, S Badve, B Jasani, E Krause, N Rioux-Leclercq, F Rojo, M Martini, L Cheng, M Tretiakova, C Mitchell, RA Anders, ME Robert, D Fahy, M Pyle, Q Le, L Yu, B Glass, V Baxi, Z Babadjanova, J Pratt, S Brutus, M Karasarides, A Hartmann | 01/04/2024 |
|
The Journal of pathology |
CA Jahangir, DB Page, G Broeckx, CA Gonzalez, C Burke, C Murphy, JS Reis-Filho, A Ly, PW Harms, RR Gupta, M Vieth, AI Hida, M Kahila, Z Kos, PJ van Diest, S Verbandt, J Thagaard, R Khiroya, K Abduljabbar, G Acosta Haab, B Acs, S Adams, JS Almeida, I Alvarado-Cabrero, F Azmoudeh-Ardalan, S Badve, NB Baharun, ER Bellolio, V Bheemaraju, KR Blenman, L Botinelly Mendonça Fujimoto, O Burgues, A Chardas, MCU Cheang, F Ciompi, LA Cooper, A Coosemans, G Corredor, FL Dantas Portela, F Deman, S Demaria, SN Dudgeon, M Elghazawy, C Fernandez-Martín, S Fineberg, SB Fox, JM Giltnane, S Gnjatic, PI Gonzalez-Ericsson, A Grigoriadis, N Halama, MG Hanna, A Harbhajanka, SN Hart, J Hartman, S Hewitt, HM Horlings, Z Husain, S Irshad, EA Janssen, TR Kataoka, K Kawaguchi, AI Khramtsov, U Kiraz, P Kirtani, LL Kodach, K Korski, G Akturk, E Scott, A Kovács, AV Laenkholm, C Lang-Schwarz, D Larsimont, JK Lennerz, M Lerousseau, X Li, A Madabhushi, SK Maley, V Manur Narasimhamurthy, DK Marks, ES McDonald, R Mehrotra, S Michiels, D Kharidehal, FUAA Minhas, S Mittal, DA Moore, S Mushtaq, H Nighat, T Papathomas, F Penault-Llorca, RD Perera, CJ Pinard, JC Pinto-Cardenas, G Pruneri, L Pusztai, NM Rajpoot, BL Rapoport, TT Rau, JM Ribeiro, D Rimm, A Vincent-Salomon, J Saltz, S Sayed, E Hytopoulos, S Mahon, KP Siziopikou, C Sotiriou, A Stenzinger, MA Sughayer, D Sur, F Symmans, S Tanaka, T Taxter, S Tejpar, J Teuwen, EA Thompson, T Tramm, WT Tran, J van der Laak, GE Verghese, G Viale, N Wahab, T Walter, Y Waumans, HY Wen, W Yang, Y Yuan, J Bartlett, S Loibl, C Denkert, P Savas, S Loi, E Specht Stovgaard, R Salgado, WM Gallagher, A Rahman | 01/03/2024 |
|
NPJ breast cancer |
JL Wright, R Gray, H Rahbar, CE Comstock, JA Tjoe, S Badve, A Recht, JA Sparano, NE Davidson, AC Wolff | 24/02/2024 |
|
Archives of pathology & laboratory medicine |
Y Lo, SC Lester, IO Ellis, S Lanjewar, J Laurini, A Patel, A Bhattarai, B Ustun, B Harmon, CG Kleer, D Ross, A Amin, Y Wang, R Bradley, G Turashvili, J Zeng, J Baum, K Singh, L Hakima, M Harigopal, M Komforti, SJ Shin, SE Abbott, S Jaffer, SS Badve, T Khoury, TM D'Alfonso, PS Ginter, V Collins, W Towne, Y Gan, A Nassar, AA Sahin, A Flieder, R Aldrees, MH Ngo, U Edema, F Sapna, SJ Schnitt, SA Fineberg | 20/01/2024 |
|
Triple Negative Breast Cancers: An Obsolete Entity? Clinical breast cancer |
M Keskinkılıc, Y Gökmen-Polar, SS Badve | 01/01/2024 |
|
Intraoperative assessment of axillary sentinel lymph nodes by telepathology. Breast cancer research and treatment |
G Turashvili, SG Gjeorgjievski, Q Wang, A Ewaz, D Ai, X Li, SS Badve | 01/12/2023 |
|
JCO precision oncology |
SR Stecklein, W Barlow, L Pusztai, K Timms, R Kennedy, GE Logan, R Seitz, S Badve, Y Gökmen-Polar, P Porter, H Linden, D Tripathy, GN Hortobagyi, AK Godwin, A Thompson, DF Hayes, P Sharma | 01/09/2023 |
|
The Journal of pathology |
J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, R Gupta, R Khiroya, K Abduljabbar, G Acosta Haab, B Acs, G Akturk, JS Almeida, I Alvarado-Cabrero, M Amgad, F Azmoudeh-Ardalan, S Badve, NB Baharun, E Balslev, ER Bellolio, V Bheemaraju, KR Blenman, L Botinelly Mendonça Fujimoto, N Bouchmaa, O Burgues, A Chardas, M Chon U Cheang, F Ciompi, LA Cooper, A Coosemans, G Corredor, AB Dahl, FL Dantas Portela, F Deman, S Demaria, J Doré Hansen, SN Dudgeon, T Ebstrup, M Elghazawy, C Fernandez-Martín, SB Fox, WM Gallagher, JM Giltnane, S Gnjatic, PI Gonzalez-Ericsson, A Grigoriadis, N Halama, MG Hanna, A Harbhajanka, SN Hart, J Hartman, S Hauberg, S Hewitt, AI Hida, HM Horlings, Z Husain, E Hytopoulos, S Irshad, EA Janssen, M Kahila, TR Kataoka, K Kawaguchi, D Kharidehal, AI Khramtsov, U Kiraz, P Kirtani, LL Kodach, K Korski, A Kovács, AV Laenkholm, C Lang-Schwarz, D Larsimont, JK Lennerz, M Lerousseau, X Li, A Ly, A Madabhushi, SK Maley, V Manur Narasimhamurthy, DK Marks, ES McDonald, R Mehrotra, S Michiels, FUAA Minhas, S Mittal, DA Moore, S Mushtaq, H Nighat, T Papathomas, F Penault-Llorca, RD Perera, CJ Pinard, JC Pinto-Cardenas, G Pruneri, L Pusztai, A Rahman, NM Rajpoot, BL Rapoport, TT Rau, JS Reis-Filho, JM Ribeiro, D Rimm, A Roslind, A Vincent-Salomon, M Salto-Tellez, J Saltz, S Sayed, E Scott, KP Siziopikou, C Sotiriou, A Stenzinger, MA Sughayer, D Sur, S Fineberg, F Symmans, S Tanaka, T Taxter, S Tejpar, J Teuwen, EA Thompson, T Tramm, WT Tran, J van der Laak, PJ van Diest, GE Verghese, G Viale, M Vieth, N Wahab, T Walter, Y Waumans, HY Wen, W Yang, Y Yuan, RM Zin, S Adams, J Bartlett, S Loibl, C Denkert, P Savas, S Loi, R Salgado, E Specht Stovgaard | 01/08/2023 |
|
The Journal of pathology |
DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, R Khiroya, Z Kos, K Abduljabbar, G Acosta Haab, B Acs, G Akturk, JS Almeida, I Alvarado-Cabrero, F Azmoudeh-Ardalan, S Badve, NB Baharun, ER Bellolio, V Bheemaraju, KR Blenman, L Botinelly Mendonça Fujimoto, N Bouchmaa, O Burgues, MCU Cheang, F Ciompi, LA Cooper, A Coosemans, G Corredor, FL Dantas Portela, F Deman, S Demaria, SN Dudgeon, M Elghazawy, S Ely, C Fernandez-Martín, S Fineberg, SB Fox, WM Gallagher, JM Giltnane, S Gnjatic, PI Gonzalez-Ericsson, A Grigoriadis, N Halama, MG Hanna, A Harbhajanka, A Hardas, SN Hart, J Hartman, S Hewitt, AI Hida, HM Horlings, Z Husain, E Hytopoulos, S Irshad, EA Janssen, M Kahila, TR Kataoka, K Kawaguchi, D Kharidehal, AI Khramtsov, U Kiraz, P Kirtani, LL Kodach, K Korski, A Kovács, AV Laenkholm, C Lang-Schwarz, D Larsimont, JK Lennerz, M Lerousseau, X Li, A Ly, A Madabhushi, SK Maley, V Manur Narasimhamurthy, DK Marks, ES McDonald, R Mehrotra, S Michiels, FUAA Minhas, S Mittal, DA Moore, S Mushtaq, H Nighat, T Papathomas, F Penault-Llorca, RD Perera, CJ Pinard, JC Pinto-Cardenas, G Pruneri, L Pusztai, A Rahman, NM Rajpoot, BL Rapoport, TT Rau, JS Reis-Filho, JM Ribeiro, D Rimm, A Vincent-Salomon, M Salto-Tellez, J Saltz, S Sayed, KP Siziopikou, C Sotiriou, A Stenzinger, MA Sughayer, D Sur, F Symmans, S Tanaka, T Taxter, S Tejpar, J Teuwen, EA Thompson, T Tramm, WT Tran, J van der Laak, PJ van Diest, GE Verghese, G Viale, M Vieth, N Wahab, T Walter, Y Waumans, HY Wen, W Yang, Y Yuan, S Adams, JMS Bartlett, S Loibl, C Denkert, P Savas, S Loi, R Salgado, E Specht Stovgaard | 01/08/2023 |
|
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc |
ME Robert, J Rüschoff, B Jasani, RP Graham, SS Badve, M Rodriguez-Justo, LL Kodach, A Srivastava, HL Wang, LH Tang, G Troncone, F Rojo, BJ Van Treeck, J Pratt, I Shnitsar, G Kumar, M Karasarides, RA Anders | 01/07/2023 |
|
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc |
ME Robert, J Rüschoff, B Jasani, RP Graham, SS Badve, M Rodriguez-Justo, LL Kodach, A Srivastava, HL Wang, LH Tang, G Troncone, F Rojo, BJ Van Treeck, J Pratt, I Shnitsa, G Kumar, M Karasarides, RA Anders | 01/05/2023 |
|
Cancers |
S Ghose, S Cho, F Ginty, E McDonough, C Davis, Z Zhang, J Mitra, AL Harris, AA Thike, PH Tan, Y Gökmen-Polar, SS Badve | 23/03/2023 |
|
A predictor of response in HER2+ breast cancer-at last! Journal of the National Cancer Institute |
SS Badve, Y Gökmen-Polar | 09/03/2023 |
|
The Role of ESRP1 in the Regulation of PHGDH in Estrogen Receptor-Positive Breast Cancer. Laboratory investigation; a journal of technical methods and pathology |
Y Gökmen-Polar, Y Gu, A Polar, X Gu, SS Badve | 01/03/2023 |
|
Artificial intelligence in breast pathology - dawn of a new era. NPJ breast cancer |
SS Badve | 31/01/2023 |
|
Quantification of spatial pharmacogene expression heterogeneity in breast tumors. Cancer reports (Hoboken, N.J.) |
NR Powell, RM Silvola, JS Howard, S Badve, TC Skaar, J Ipe | 01/01/2023 |
|
Targeting the Tumor-Tumor Microenvironment Crosstalk. Expert opinion on therapeutic targets |
SS Badve, Y Gökmen-Polar | 01/01/2023 |
|
Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy. Frontiers in oncology |
CB Koppiker, DA Kelkar, M Kulkarni, S Kadu, M Pai, U Dhar, C Deshmukh, B Varghese, V Zamre, N Jumle, N Gangurde, A Joshi, R Unde, R Banale, N Namewar, P Vaid, L Busheri, G Thomas, S Nare, J Pereira, S Badve | 01/01/2023 |
|
JCO global oncology |
S Joshi, R Mishra, M Kulkarni, DA Kelkar, K Harikrishnan, P Vaid, G V, J John, S Tamhane, A Deshpande, S Badve, null Chintamani, R Mehrotra, LS Shashidhara, A Kothari, C Koppiker | 01/01/2023 |
|
Breast Implant Capsule-Associated Squamous Cell Carcinoma: Report of 2 Patients. International journal of surgical pathology |
RD Whaley, R Aldrees, RE Dougherty, C Prieto Granada, SS Badve, S Al Diffalha | 01/12/2022 |
|
Applied immunohistochemistry & molecular morphology : AIMM |
M Komforti, E Downs-Kelly, F Sapunar, SR Wijayawardana, AM Gruver, SS Badve | 01/09/2022 |
|
Spatially variant immune infiltration scoring in human cancer tissues. NPJ precision oncology |
M Allam, T Hu, J Lee, J Aldrich, SS Badve, Y Gökmen-Polar, M Bhave, SS Ramalingam, F Schneider, AF Coskun | 01/09/2022 |
|
Cancers |
SS Badve, S Cho, X Lu, S Cao, S Ghose, AA Thike, PH Tan, IT Ocal, D Generali, F Zanconati, AL Harris, F Ginty, Y Gökmen-Polar | 13/08/2022 |
|
Clinical cancer research : an official journal of the American Association for Cancer Research |
M Radovich, JP Solzak, CJ Wang, BA Hancock, S Badve, SK Althouse, SM Bray, AMV Storniolo, TJ Ballinger, BP Schneider, KD Miller | 02/08/2022 |
|
Clinical breast cancer |
R Caparica, Y Ma, C De Angelis, F Richard, C Desmedt, A Awada, M Piccart, EA Perez, A Moreno-Aspitia, S Badve, EA Thompson, E de Azambuja | 01/06/2022 |
|
Journal of the National Cancer Institute |
SS Badve, F Penault-Llorca, JS Reis-Filho, R Deurloo, KP Siziopikou, C D'Arrigo, G Viale | 09/05/2022 |
|
Journal of nephrology |
B Bose, EYM Chung, R Hong, GFM Strippoli, DW Johnson, WL Yang, SV Badve, SC Palmer | 01/05/2022 |
|
Is conservative management of ductal carcinoma in situ risky? NPJ breast cancer |
L Zheng, Y Gökmen-Polar, SS Badve | 28/04/2022 |
|
Protein Profiling of Breast Cancer for Treatment Decision-Making. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting |
SS Badve, Y Gökmen-Polar | 01/04/2022 |
|
Breast cancer research and treatment |
TTA Nguyen, LM Postlewait, C Zhang, JL Meisel, R O'Regan, S Badve, K Kalinsky, X Li | 01/04/2022 |
|
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management. Endocrinology |
SL Hophan, O Odnokoz, H Liu, Y Luo, S Khan, W Gradishar, Z Zhou, S Badve, MA Torres, Y Wan | 01/04/2022 |
|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
BP Schneider, G Jiang, TJ Ballinger, F Shen, C Chitambar, R Nanda, C Falkson, FC Lynce, C Gallagher, C Isaacs, M Blaya, E Paplomata, R Walling, K Daily, R Mahtani, MA Thompson, R Graham, ME Cooper, DC Pavlick, LA Albacker, J Gregg, JP Solzak, YH Chen, CL Bales, E Cantor, BA Hancock, N Kassem, P Helft, B O'Neil, AMV Storniolo, S Badve, KD Miller, M Radovich | 01/02/2022 |
|
NPJ breast cancer |
S Loi, R Salgado, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, H Joensuu, MV Dieci, S Badve, S Demaria, R Gray, E Munzone, D Drubay, J Lemonnier, C Sotiriou, PL Kellokumpu-Lehtinen, A Vingiani, K Gray, F André, C Denkert, M Piccart, E Roblin, S Michiels | 11/01/2022 |
|
A phase II study of buparlisib in relapsed or refractory thymomas. Frontiers in oncology |
MI Abu Zaid, M Radovich, S Althouse, H Liu, AJ Spittler, J Solzak, S Badve, PJ Loehrer | 01/01/2022 |
|
Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD. Journal of the American Society of Nephrology : JASN |
NM Lioufas, EM Pascoe, CM Hawley, GJ Elder, SV Badve, GA Block, DW Johnson, ND Toussaint | 01/01/2022 |
|
NPJ breast cancer |
K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, JR de Freitas, D Sur, LC Amendola, M Gharib, A Kallala, I Arun, F Azmoudeh-Ardalan, L Fujimoto, LF Sua, SW Liu, HC Lien, P Kirtani, M Balancin, H El Attar, P Guleria, W Yang, E Shash, IC Chen, V Bautista, JF Do Prado Moura, BL Rapoport, C Castaneda, E Spengler, G Acosta-Haab, I Frahm, J Sanchez, M Castillo, N Bouchmaa, RR Md Zin, R Shui, T Onyuma, W Yang, Z Husain, K Willard-Gallo, A Coosemans, EA Perez, E Provenzano, PG Ericsson, E Richardet, R Mehrotra, S Sarancone, A Ehinger, DL Rimm, JMS Bartlett, G Viale, C Denkert, AI Hida, C Sotiriou, S Loibl, SM Hewitt, S Badve, WF Symmans, RS Kim, G Pruneri, S Goel, PA Francis, G Inurrigarro, R Yamaguchi, H Garcia-Rivello, H Horlings, S Afqir, R Salgado, S Adams, M Kok, MV Dieci, S Michiels, S Demaria, S Loi | 01/12/2021 |
|
Radiology |
SS Chou, J Romanoff, CD Lehman, SA Khan, R Carlos, SS Badve, J Xiao, RL Corsetti, SH Javid, DW Spell, LK Han, JL Sabol, JR Bumberry, IF Gareen, BS Snyder, C Gatsonis, LI Wagner, AC Wolff, KD Miller, JA Sparano, CE Comstock, H Rahbar | 01/10/2021 |
|
Radiology |
SS Chou, J Romanoff, CD Lehman, SA Khan, R Carlos, SS Badve, J Xiao, RL Corsetti, SH Javid, DW Spell, LK Han, JL Sabol, JR Bumberry, IF Gareen, BS Snyder, C Gatsonis, LI Wagner, AC Wolff, KD Miller, JA Sparano, CE Comstock, H Rahbar | 01/10/2021 |
Dr. Badve has been the recipient of Bantz-Petronio Award for Translating Research into Practice at Indiana University. He has received the Vladimir Totović Award from the International Academy of Pathology- German Division and has been recognized as a Komen Scholar by Susan G. Komen Foundation multiple times.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
